动脉切开封堵器市场规模、份额及成长分析（按产品、应用、最终用户和地区划分）－2026-2033年产业预测

全球动脉切开术闭合装置市场规模预计在 2024 年达到 19.4 亿美元，从 2025 年的 20.8 亿美元成长到 2033 年的 37.1 亿美元，在预测期（2026-2033 年）内复合年增长率为 7.5%。

全球动脉切口闭合装置市场正经历强劲成长，主要驱动因素是心血管疾病（CVD）盛行率的不断上升，而心血管疾病是全球首要死因。血管成形术和冠状动脉导管插入术等介入手术数量的增加，推动了对可靠动脉切口闭合解决方案的需求。医院仍然是主要的终端用户，因为高频手术，尤其是涉及大口径导管的手术，主要集中在专科中心。然而，由于门诊血管手术具有成本效益高、週转快等优点，市场对门诊血管手术的需求日益增长，因此，门诊手术中心（ASC）的使用量正在显着增加。儘管中低收入国家面临许多挑战，但市场相关人员正致力于地域扩张和提高产品可负担性，推动创新以改善这些地区的医疗服务。

全球动脉切开术闭合装置市场驱动因素

冠动脉摄影术、经皮冠状动脉介入治疗（PCI）、经导管主动脉瓣置换术术（TAVR）和周边血管介入等介入性手术的日益增多，是推动动脉切开封堵器需求成长的主要因素。随着医疗机构致力于改善患者预后，快速止血、缩短恢復时间和减少併发症（包括血肿和出血）的需求也日益凸显。这种变化凸显了血管闭合装置在导管术后股动脉和桡动脉入路管理中的关键作用，巩固了其作为现代医学必备工具的地位，并促进了这些装置的市场蓬勃发展。

限制全球动脉切开术闭合装置市场的因素

先进动脉切开封堵器的广泛应用，尤其是在发展中地区，面临的一大障碍是这些系统的高成本。虽然手动压迫仍然是一种经济的选择，但由于报销不足、价格敏感以及缺乏必要的基础设施，预算紧张的医疗机构不愿采用新技术。因此，东南亚和拉丁美洲等新兴市场的许多医院由于先进设备成本高昂，主要依赖手动闭合方法，这阻碍了该领域的发展，儘管现代解决方案具有潜在的优势。

全球动脉切开术闭合装置市场趋势

全球动脉切口闭合器械市场正经历着向微创手术技术的重大转变，这主要得益于市场对高效血管手术（可促进患者康復）需求的不断增长。随着医疗系统越来越多地采用经导管主动脉瓣置换术术 (TAVR) 和血管内动脉瘤修復术 (EVAR) 等大口径介入治疗，对能够快速止血并改善手术效果的创新型血管闭合器材的需求也随之激增。这一趋势在已开发市场和新兴市场均尤为明显，器械技术的进步使得器械能够快速部署并实现更精准的操作控制，从而最大限度地减少併发症，并支持复杂介入性心臟病学和血管外科手术的拓展。

目录

介绍

• 调查目标
• 调查范围
• 定义

调查方法

• 资讯收集
• 二手资料和一手资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分市场机会分析

市场动态与展望

• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特分析

关键市场考察

• 关键成功因素
• 竞争程度
• 关键投资机会
• 市场生态系统
• 市场吸引力指数（2025）
• PESTEL 分析
• 总体经济指标
• 价值链分析
• 定价分析
• 技术分析
• 案例研究
• 顾客购买行为分析

全球动脉切开封堵器市场规模（按产品和复合年增长率划分）（2026-2033 年）

• 主动闭合装置
• 被动闭合装置

全球动脉切开封堵器市场规模（按应用及复合年增长率划分）（2026-2033 年）

• 股动脉路手术
• 桡动脉入路手术

全球动脉切开封堵器市场规模（依最终用户划分）及复合年增长率（2026-2033 年）

• 医院
• 门诊治疗中心
• 其他的

全球动脉切开封堵器市场规模及复合年增长率（2026-2033）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 亚太其他地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地区
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前五大公司对比
• 主要企业的市场定位（2025 年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市占率分析（2025 年）
• 主要企业公司简介
  • 公司详情
  • 产品系列分析
  • 依业务板块进行公司股票分析
  • 2023-2025年营收年比比较

主要企业简介

• Abbott Laboratories
• Terumo Corporation
• Cardinal Health（Cordis）
• Boston Scientific Corporation
• Medtronic plc
• Teleflex Incorporated（Vascular Solutions）
• Vivasure Medical Ltd.
• TZ Medical, Inc.
• Meril Life Sciences Pvt. Ltd.
• Morris Innovative, Inc.

结论与建议

Global Arteriotomy Closure Devices Market size was valued at USD 1.94 Billion in 2024 and is poised to grow from USD 2.08 Billion in 2025 to USD 3.71 Billion by 2033, growing at a CAGR of 7.5% during the forecast period (2026-2033).

The global arteriotomy closure devices market is experiencing robust growth, largely driven by the increasing prevalence of cardiovascular diseases (CVDs), which are the leading cause of mortality worldwide. As the volume of interventional procedures like angioplasty and coronary catheterization rises, the need for reliable arteriotomy closure solutions is intensifying. Hospitals remain the primary end-users due to the concentration of high-volume procedures in specialized centers, particularly those involving large bore catheter access. However, there is a notable shift towards ambulatory surgical centers (ASCs), reflecting a growing demand for outpatient vascular procedures driven by cost-efficiency and rapid recovery. Despite challenges in low- and middle-income countries, market players are focusing on geographic expansion and affordability, fostering innovation to enhance healthcare delivery in these regions.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Arteriotomy Closure Devices market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Arteriotomy Closure Devices Market Segments Analysis

Global Arteriotomy Closure Devices Market is segmented by Product, Application, End User and region. Based on Product, the market is segmented into Active Closure Devices and Passive Closure Devices. Based on Application, the market is segmented into Femoral Arterial Access Procedures and Radial Arterial Access Procedures. Based on End User, the market is segmented into Hospitals, Ambulatory Care Centers and Other. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Arteriotomy Closure Devices Market

The increasing prevalence of interventional procedures, such as coronary angiography, percutaneous coronary intervention (PCI), transcatheter aortic valve replacement (TAVR), and peripheral artery interventions, is significantly driving the demand for arteriotomy closure devices. As healthcare providers seek to enhance patient outcomes, there is a growing emphasis on the need for rapid hemostasis, minimized recovery times, and reduced complications, including hematoma and bleeding. This evolving landscape highlights the essential role of vascular closure devices in managing femoral and radial access during post-catheterization care, positioning them as indispensable tools in contemporary medical practice and contributing to a robust market for these devices.

Restraints in the Global Arteriotomy Closure Devices Market

A significant barrier to the wider adoption of advanced arteriotomy closure devices, particularly in developing regions, is the high cost associated with these systems. While manual compression remains an economical option, institutions in budget-limited markets hesitate to transition to newer technologies due to inadequate reimbursement frameworks, sensitivity to pricing policies, and a lack of necessary infrastructure. As a result, many hospitals in emerging markets, such as those in Southeast Asia and Latin America, primarily rely on manual closure methods due to the unaffordability of advanced devices, hindering progress in the field despite the potential benefits of modern solutions.

Market Trends of the Global Arteriotomy Closure Devices Market

The Global Arteriotomy Closure Devices market is witnessing a significant shift towards minimally invasive surgical techniques, driven by the rising preference for efficient vascular procedures that enhance patient recovery. As healthcare systems increasingly adopt large-bore interventions, such as Transcatheter Aortic Valve Replacement (TAVR) and Endovascular Aneurysm Repair (EVAR), the demand for innovative vascular closure devices capable of providing rapid hemostasis and improved surgical outcomes is intensifying. This trend is particularly prominent in both developed and emerging markets, where advancements in device technology enable faster deployment and superior operator control, thus minimizing complications and supporting the expansion of complex interventional cardiology and vascular surgery practices.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Technology Analysis
• Case Studies
• Customer Buying Behavior Analysis

Global Arteriotomy Closure Devices Market Size by Product & CAGR (2026-2033)

• Market Overview
• Active Closure Devices
• Passive Closure Devices

Global Arteriotomy Closure Devices Market Size by Application & CAGR (2026-2033)

• Market Overview
• Femoral Arterial Access Procedures
• Radial Arterial Access Procedures

Global Arteriotomy Closure Devices Market Size by End User & CAGR (2026-2033)

• Market Overview
• Hospitals
• Ambulatory Care Centers
• Other

Global Arteriotomy Closure Devices Market Size & CAGR (2026-2033)

• North America (Product, Application, End User)
  • US
  • Canada
• Europe (Product, Application, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product, Application, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product, Application, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, Application, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Abbott Laboratories
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Terumo Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cardinal Health (Cordis)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boston Scientific Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic plc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Teleflex Incorporated (Vascular Solutions)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Vivasure Medical Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• TZ Medical, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Meril Life Sciences Pvt. Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Morris Innovative, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations